These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30173356)

  • 41. Down-regulation of basal Fos expression at nucleus tractus solitarii underlies restoration of baroreflex response after antihypertensive treatment in spontaneously hypertensive rats.
    Chan SH; Chao YM; Tseng CJ; Chan JY
    Neuroscience; 2002; 112(1):113-20. PubMed ID: 12044476
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Possible beneficial effect of peroxisome proliferator-activated receptor (PPAR)--α and γ agonist against a rat model of oral dyskinesia.
    Grover S; Kumar P; Singh K; Vikram V; Budhiraja RD
    Pharmacol Biochem Behav; 2013 Oct; 111():17-23. PubMed ID: 23948071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PPAR-γ agonist, pioglitazone, reduced oxidative and endoplasmic reticulum stress associated with L-NAME-induced hypertension in rats.
    Soliman E; Behairy SF; El-Maraghy NN; Elshazly SM
    Life Sci; 2019 Dec; 239():117047. PubMed ID: 31730865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peroxisome proliferator-activated receptor alpha and alpha/gamma agonists do not cause impairment in renal function in the rat.
    Ovcharenko E; Hansen MK; Goltsman I; Abu-Saleh N; Abassi Z; Walsh K; Miele G; Feuerstein GZ; Winaver J
    Nephron Physiol; 2010; 115(3):p21-30. PubMed ID: 20460939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of single and combined PPAR-α and PPAR-γ activation on the neurological outcomes following cerebral ischemia reperfusion.
    Shehata AHF; Ahmed AF; Abdelrehim AB; Heeba GH
    Life Sci; 2020 Jul; 252():117679. PubMed ID: 32325134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of UCP2 in the protective effects of PPARβ/δ activation on lipopolysaccharide-induced endothelial dysfunction.
    Toral M; Romero M; Jiménez R; Robles-Vera I; Tamargo J; Martínez MC; Pérez-Vizcaíno F; Duarte J
    Biochem Pharmacol; 2016 Jun; 110-111():25-36. PubMed ID: 27179975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
    Kar D; Bandyopadhyay A
    Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PPAR-α Agonist Improves Hyperglycemia-Induced Oxidative Stress in Pancreatic Cells by Potentiating Antioxidant Defense System.
    Yaribeygi H; Mohammadi MT; Sahebkar A
    Drug Res (Stuttg); 2018 Jun; 68(6):355-360. PubMed ID: 29433142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes or peroxisome proliferator-activated receptor alpha agonist increases mitochondrial thioesterase I activity in heart.
    King KL; Young ME; Kerner J; Huang H; O'Shea KM; Alexson SE; Hoppel CL; Stanley WC
    J Lipid Res; 2007 Jul; 48(7):1511-7. PubMed ID: 17438340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy.
    Yaribeygi H; Mohammadi MT; Rezaee R; Sahebkar A
    J Cell Biochem; 2018 Sep; 119(9):7458-7469. PubMed ID: 29761900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension.
    Iglarz M; Touyz RM; Amiri F; Lavoie MF; Diep QN; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):45-51. PubMed ID: 12524223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation.
    Koh EH; Kim MS; Park JY; Kim HS; Youn JY; Park HS; Youn JH; Lee KU
    Diabetes; 2003 Sep; 52(9):2331-7. PubMed ID: 12941773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peroxisome proliferator-activated receptors γ/mitochondrial uncoupling protein 2 signaling protects against seizure-induced neuronal cell death in the hippocampus following experimental status epilepticus.
    Chuang YC; Lin TK; Huang HY; Chang WN; Liou CW; Chen SD; Chang AY; Chan SH
    J Neuroinflammation; 2012 Jul; 9():184. PubMed ID: 22849356
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contraction-sensitive skeletal muscle afferents inhibit arterial baroreceptor signalling in the nucleus of the solitary tract: role of intrinsic GABA interneurons.
    Potts JT; Paton JF; Mitchell JH; Garry MG; Kline G; Anguelov PT; Lee SM
    Neuroscience; 2003; 119(1):201-14. PubMed ID: 12763081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
    Ge J; Miao JJ; Sun XY; Yu JY
    J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury.
    Chen XR; Besson VC; Palmier B; Garcia Y; Plotkine M; Marchand-Leroux C
    J Neurotrauma; 2007 Jul; 24(7):1119-31. PubMed ID: 17610352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of peroxisome proliferator-activated receptor ligands in modulating tissue factor and tissue factor pathway inhibitor in acutely symptomatic carotid atheromas.
    Golledge J; Mangan S; Clancy P
    Stroke; 2007 May; 38(5):1501-8. PubMed ID: 17363721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interaction between irbesartan, peroxisome proliferator-activated receptor (PPAR-γ), and adiponectin in the regulation of blood pressure and renal function in spontaneously hypertensive rats.
    Afzal S; Sattar MA; Johns EJ; Abdulla MH; Akhtar S; Hashmi F; Abdullah NA
    J Physiol Biochem; 2016 Dec; 72(4):593-604. PubMed ID: 27405250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PPAR Agonists: I. Role of Receptor Subunits in Alcohol Consumption in Male and Female Mice.
    Blednov YA; Black M; Benavidez JM; Stamatakis EE; Harris RA
    Alcohol Clin Exp Res; 2016 Mar; 40(3):553-62. PubMed ID: 26857685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of pioglitazone and fenofibrate co-administration on bone biomechanics and histomorphometry in ovariectomized rats.
    Smith SY; Samadfam R; Chouinard L; Awori M; Bénardeau A; Bauss F; Guldberg RE; Sebokova E; Wright MB
    J Bone Miner Metab; 2015 Nov; 33(6):625-41. PubMed ID: 25534548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.